Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Dec 19;92(26):12175–12179. doi: 10.1073/pnas.92.26.12175

Identification of the galactose-adherence lectin epitopes of Entamoeba histolytica that stimulate tumor necrosis factor-alpha production by macrophages.

R Séguin 1, B J Mann 1, K Keller 1, K Chadee 1
PMCID: PMC40319  PMID: 8618866

Abstract

The 170-kDa subunit of the galactose-adherence lectin (Gal-lectin) of Entamoeba histolytica mediates adherence to human colonic mucins and intestinal epithelium as a prerequisite to amebic invasion. The Gal-lectin is an immunodominant molecule and a protective antigen in the gerbil model of amebiasis. Tumor necrosis factor alpha (TNF-alpha) produced by activated macrophages enhances nitric oxide-dependent cytotoxicity in host defense against E. histolytica. The purpose of this study was to identify the Gal-lectin epitopes which stimulate TNF-alpha production by macrophages. Murine bone marrow-derived macrophages (BMMs) exposed to Gal-lectin (100-500 ng/ml) stimulated stable expression of TNF-alpha mRNA (8-fold increase) and TNF-alpha production similar to that of lipopolysaccharide-stimulated cells (100 ng/ml). Polyclonal anti-lectin serum specifically inhibited TNF-alpha mRNA induction in response to the Gal-lectin but not to lipopolysaccharide. Anti-lectin monoclonal antibodies 8C12, H85 and 1G7, which recognize nonoverlapping epitopes of the cysteine-rich region of the 170-kDa heavy subunit, inhibited both amebic adherence to mammalian cells and Gal-lectin-stimulated TNF-alpha mRNA expression by BMMs,but monoclonal antibody 7F4 did neither. As these inhibitory antibodies map to amino acids 596-1082 of the 170-kDa Gal-lectin, our results have identified the functional region that mediates amebic adherence and TNF-alpha mRNA induction in BMMMs; thus, this region of the Gal-lectin is a subunit vaccine candidate.

Full text

PDF
12175

Images in this article

12176Fig. 1
on p.12176
12177Fig. 2
on p.12177
12177Fig. 3
on p.12177
12178Fig. 4
on p.12178
12178Fig. 6
on p.12178

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alonso P. L., Smith T., Schellenberg J. R., Masanja H., Mwankusye S., Urassa H., Bastos de Azevedo I., Chongela J., Kobero S., Menendez C. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet. 1994 Oct 29;344(8931):1175–1181. doi: 10.1016/s0140-6736(94)90505-3. [DOI] [PubMed] [Google Scholar]
  2. Calderón J., de Lourdes Muñoz M., Acosta H. M. Surface redistribution and release of antibody-induced caps in entamoebae. J Exp Med. 1980 Jan 1;151(1):184–193. doi: 10.1084/jem.151.1.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chadee K., Petri W. A., Jr, Innes D. J., Ravdin J. I. Rat and human colonic mucins bind to and inhibit adherence lectin of Entamoeba histolytica. J Clin Invest. 1987 Nov;80(5):1245–1254. doi: 10.1172/JCI113199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Denis M., Chadee K. Cytokine activation of murine macrophages for in vitro killing of Entamoeba histolytica trophozoites. Infect Immun. 1989 Jun;57(6):1750–1756. doi: 10.1128/iai.57.6.1750-1756.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Denis M., Chadee K. Immunopathology of Entamoeba histolytica infections. Parasitol Today. 1988 Sep;4(9):247–252. doi: 10.1016/0169-4758(88)90139-1. [DOI] [PubMed] [Google Scholar]
  6. Denis M., Chadee K. In vitro and in vivo studies of macrophage functions in amebiasis. Infect Immun. 1988 Dec;56(12):3126–3131. doi: 10.1128/iai.56.12.3126-3131.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ghadirian E., Meerovitch E., Hartmann D. P. Protection against amebic liver abscess in hamsters by means of immunization with amebic antigen and some of its fractions. Am J Trop Med Hyg. 1980 Sep;29(5):779–784. doi: 10.4269/ajtmh.1980.29.779. [DOI] [PubMed] [Google Scholar]
  8. Ghadirian E., Meerovitch E. Vaccination against hepatic amebiasis in hamsters. J Parasitol. 1978 Aug;64(4):742–743. [PubMed] [Google Scholar]
  9. Irusen E. M., Jackson T. F., Simjee A. E. Asymptomatic intestinal colonization by pathogenic Entamoeba histolytica in amebic liver abscess: prevalence, response to therapy, and pathogenic potential. Clin Infect Dis. 1992 Apr;14(4):889–893. doi: 10.1093/clinids/14.4.889. [DOI] [PubMed] [Google Scholar]
  10. Kelsall B. L., Jackson T. G., Gathiram V., Salig S. B., Vaithilingum M., Pearson R. D., Ravdin J. I. Secretory immunoglobulin A antibodies to the galactose-inhibitable adherence protein in the saliva of patients with amebic liver disease. Am J Trop Med Hyg. 1994 Oct;51(4):454–459. [PubMed] [Google Scholar]
  11. Kelsall B. L., Ravdin J. I. Degradation of human IgA by Entamoeba histolytica. J Infect Dis. 1993 Nov;168(5):1319–1322. doi: 10.1093/infdis/168.5.1319. [DOI] [PubMed] [Google Scholar]
  12. Kelsall B. L., Ravdin J. I. Immunization of rats with the 260-kilodalton Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence-inhibitory activity. Infect Immun. 1995 Feb;63(2):686–689. doi: 10.1128/iai.63.2.686-689.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lin J. Y., Chadee K. Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from L-arginine. J Immunol. 1992 Jun 15;148(12):3999–4005. [PubMed] [Google Scholar]
  14. Lin J. Y., Seguin R., Keller K., Chadee K. Tumor necrosis factor alpha augments nitric oxide-dependent macrophage cytotoxicity against Entamoeba histolytica by enhanced expression of the nitric oxide synthase gene. Infect Immun. 1994 May;62(5):1534–1541. doi: 10.1128/iai.62.5.1534-1541.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mann B. J., Chung C. Y., Dodson J. M., Ashley L. S., Braga L. L., Snodgrass T. L. Neutralizing monoclonal antibody epitopes of the Entamoeba histolytica galactose adhesin map to the cysteine-rich extracellular domain of the 170-kilodalton subunit. Infect Immun. 1993 May;61(5):1772–1778. doi: 10.1128/iai.61.5.1772-1778.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McCoy J. J., Mann B. J., Vedvick T. S., Pak Y., Heimark D. B., Petri W. A., Jr Structural analysis of the light subunit of the Entamoeba histolytica galactose-specific adherence lectin. J Biol Chem. 1993 Nov 15;268(32):24223–24231. [PubMed] [Google Scholar]
  17. Nain P. C., Vinayak V. K. Elicitation of protective immunity to Entamoeba histolytica--an experimental study. Immunol Cell Biol. 1987 Jun;65(Pt 3):217–222. doi: 10.1038/icb.1987.24. [DOI] [PubMed] [Google Scholar]
  18. Petri W. A., Jr, Joyce M. P., Broman J., Smith R. D., Murphy C. F., Ravdin J. I. Recognition of the galactose- or N-acetylgalactosamine-binding lectin of Entamoeba histolytica by human immune sera. Infect Immun. 1987 Oct;55(10):2327–2331. doi: 10.1128/iai.55.10.2327-2331.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Petri W. A., Jr, Ravdin J. I. Protection of gerbils from amebic liver abscess by immunization with the galactose-specific adherence lectin of Entamoeba histolytica. Infect Immun. 1991 Jan;59(1):97–101. doi: 10.1128/iai.59.1.97-101.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Petri W. A., Jr, Smith R. D., Schlesinger P. H., Murphy C. F., Ravdin J. I. Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica. J Clin Invest. 1987 Nov;80(5):1238–1244. doi: 10.1172/JCI113198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Petri W. A., Jr, Snodgrass T. L., Jackson T. F., Gathiram V., Simjee A. E., Chadee K., Chapman M. D. Monoclonal antibodies directed against the galactose-binding lectin of Entamoeba histolytica enhance adherence. J Immunol. 1990 Jun 15;144(12):4803–4809. [PubMed] [Google Scholar]
  22. Ravdin J. I., Guerrant R. L. Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes. J Clin Invest. 1981 Nov;68(5):1305–1313. doi: 10.1172/JCI110377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Salata R. A., Martinez-Palomo A., Murray H. W., Conales L., Trevino N., Segovia E., Murphy C. F., Ravdin J. I. Patients treated for amebic liver abscess develop cell-mediated immune responses effective in vitro against Entamoeba histolytica. J Immunol. 1986 Apr 1;136(7):2633–2639. [PubMed] [Google Scholar]
  24. Salata R. A., Murray H. W., Rubin B. Y., Ravdin J. I. The role of gamma interferon in the generation of human macrophages cytotoxic for Entamoeba histolytica trophozoites. Am J Trop Med Hyg. 1987 Jul;37(1):72–78. doi: 10.4269/ajtmh.1987.37.72. [DOI] [PubMed] [Google Scholar]
  25. Salata R. A., Pearson R. D., Ravdin J. I. Interaction of human leukocytes and Entamoeba histolytica. Killing of virulent amebae by the activated macrophage. J Clin Invest. 1985 Aug;76(2):491–499. doi: 10.1172/JCI111998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schain D. C., Salata R. A., Ravdin J. I. Human T-lymphocyte proliferation, lymphokine production, and amebicidal activity elicited by the galactose-inhibitable adherence protein of Entamoeba histolytica. Infect Immun. 1992 May;60(5):2143–2146. doi: 10.1128/iai.60.5.2143-2146.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Seguin R., Keller K., Chadee K. Entamoeba histolytica stimulates the unstable transcription of c-fos and tumour necrosis factor-alpha mRNA by protein kinase C signal transduction in macrophages. Immunology. 1995 Sep;86(1):49–57. [PMC free article] [PubMed] [Google Scholar]
  28. Soong C. J., Kain K. C., Abd-Alla M., Jackson T. F., Ravdin J. I. A recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess. J Infect Dis. 1995 Mar;171(3):645–651. doi: 10.1093/infdis/171.3.645. [DOI] [PubMed] [Google Scholar]
  29. Stern J. J., Graybill J. R., Drutz D. J. Murine amebiasis: the role of the macrophage in host defense. Am J Trop Med Hyg. 1984 May;33(3):372–380. doi: 10.4269/ajtmh.1984.33.372. [DOI] [PubMed] [Google Scholar]
  30. Vinayak V. K., Sawhney S., Jain P., Chakravarti R. N. Protective effects of crude and chromatographic fractions of axenic Entamoeba histolytica in guinea-pigs. Trans R Soc Trop Med Hyg. 1980;74(4):483–487. doi: 10.1016/0035-9203(80)90063-2. [DOI] [PubMed] [Google Scholar]
  31. Walsh J. A. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis. 1986 Mar-Apr;8(2):228–238. doi: 10.1093/clinids/8.2.228. [DOI] [PubMed] [Google Scholar]
  32. Wang W., Chadee K. Entamoeba histolytica suppresses gamma interferon-induced macrophage class II major histocompatibility complex Ia molecule and I-A beta mRNA expression by a prostaglandin E2-dependent mechanism. Infect Immun. 1995 Mar;63(3):1089–1094. doi: 10.1128/iai.63.3.1089-1094.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wang W., Keller K., Chadee K. Modulation of tumor necrosis factor production by macrophages in Entamoeba histolytica infection. Infect Immun. 1992 Aug;60(8):3169–3174. doi: 10.1128/iai.60.8.3169-3174.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Zhang T., Cieslak P. R., Stanley S. L., Jr Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen. Infect Immun. 1994 Apr;62(4):1166–1170. doi: 10.1128/iai.62.4.1166-1170.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES